INTERNATIONAL PATENT: SANOFI FILES APPLICATION FOR "METHODS AND USES FOR ANTI-CD38 T CELL ENGAGERS IN TREATMENT OF PERIPHERAL T-CELL LYMPHOMAS"

GENEVA, Feb. 10 -- SANOFI (46 avenue de la Grande Armee75017 PARIS) filed a patent application (PCT/EP2024/071517) for "METHODS AND USES FOR ANTI-CD38 T CELL ENGAGERS IN TREATMENT OF PERIPHERAL T-CELL LYMPHOMAS" on Jul 30, 2024. With publication no. WO/2025/027003, the details related to the patent application was published on Feb 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VAN DE VELDE, Helgi (c/o Sanofi-Aventis BelgiumPatent DepartmentLeonardo Da Vinci Laan 19, Airport Plaza - Montreal Building1831 DIEGEM)

Abstract: The disclosure provides methods for treating peripheral T-cell ...